Roche Applied Science
 | |
| Public (NYSE: PKI) | |
| Industry | Health Sciences, Pharmacology, Biotechnology |
| Headquarters | Penzberg, Upper Bavaria, Germany |
| Products | Analytical instruments, Genetic Screening tools, Life & Analytical Science software and instruments |
| Website | www.www.roche-applied-science.com |
Roche Applied Science is a global business entity in the biotechnology sector that produces reagents and systems for life sciences research, with an emphasis on molecular genetics and cell biology research needs.
Scope of business
Roche Applied Science produces reagents and systems for related to DNA sequencing, microarrays, gene expression, and cell analysis. Important fields of application of the company's products are the research and development areas of the biotechnology and pharmaceutical industries. The company also offers reagents and systems for the pharmaceuticals and diagnostics industries.
Locations
The company's headquarters is in Penzberg in Upper Bavaria, Germany; other main sites are Mannheim, Germany, Rotkreuz in Switzerland, Madison, WI, Pleasanton, CA, and Branford, CT in the United States.
History
Roche Applied Science was founded in 1859 as Boehringer Mannheim, a developer of rare chemicals and pharmaceuticals. In the 1950s, the bioreagents product line was developed according to the company’s own needs in diagnostics research. They were the first commercially important producer of restriction enzymes, they were the first supplier of Klenow enzyme for Sanger sequencing, and they are the only supplier of a system for the non-radioactive labeling of nucleic acid.
Instrument development
As of 2011, Roche Applied Science's instrumentation products included genome sequencing platforms, an instrument to perform automated polymerase chain reactions (PCR) and product analyses, and a system for real-time, label-free cellular analysis for use in cell invasion/migration studies.
Roche has a history of both developing new technologies, and licensing them from other companies.